Cart is empty Shares in Japan’s Daiichi Sankyo soared on Friday after the pharma group announced a major cancer drug deal with US giant Merck worth up to $22 billion.
Shares in Japan’s Daiichi Sankyo soared on Friday after the pharma group announced a major cancer drug deal with US giant Merck worth up to $22 billion.
Leave A Comment